These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35798882)

  • 1. Emerging role of exosomes in hematological malignancies.
    Pandian SRK; Vijayakumar KK; Kunjiappan S; Babkiewicz E; Maszczyk P
    Clin Exp Med; 2023 Aug; 23(4):1123-1136. PubMed ID: 35798882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.
    Huang W; Paul D; Calin GA; Bayraktar R
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current knowledge on therapeutic, diagnostic, and prognostics applications of exosomes in multiple myeloma: Opportunities and challenges.
    Ramezani A; Tafazoli A; Salimi F; Ghavami M; Arjmandi H; Khalesi B; Hashemi ZS; Khalili S
    Arch Biochem Biophys; 2024 Jun; 756():109994. PubMed ID: 38626818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes.
    Iaccino E; Mimmi S; Dattilo V; Marino F; Candeloro P; Di Loria A; Marimpietri D; Pisano A; Albano F; Vecchio E; Ceglia S; Golino G; Lupia A; Fiume G; Quinto I; Scala G
    Mol Cancer; 2017 Oct; 16(1):159. PubMed ID: 29029605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia cancer cells and immune cells derived-exosomes: Possible roles in leukemia progression and therapy.
    Salman DM; Mohammad TAM
    Cell Biochem Funct; 2024 Mar; 42(2):e3960. PubMed ID: 38424731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Based Approaches for Treatment of Hematological Malignancies: a Comprehensive Review.
    Hani U; Gowda BHJ; Haider N; Ramesh K; Paul K; Ashique S; Ahmed MG; Narayana S; Mohanto S; Kesharwani P
    AAPS PharmSciTech; 2023 Nov; 24(8):233. PubMed ID: 37973643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematological involvement in sarcoidosis: from cytopenias to lymphoma.
    Brito-Zerón P; Lower EE; Ramos-Casals M; Baughman RP
    Expert Rev Clin Immunol; 2024; 20(1):59-70. PubMed ID: 37878359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the nexus of nuclear receptors in hematological malignancies.
    Manickasamy MK; Sajeev A; BharathwajChetty B; Alqahtani MS; Abbas M; Hegde M; Aswani BS; Shakibaei M; Sethi G; Kunnumakkara AB
    Cell Mol Life Sci; 2024 Feb; 81(1):78. PubMed ID: 38334807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of a heptamer-type sgRNA library for potential therapeutic agents against hematological malignancies.
    Takahashi M; Elbarbary RA; Watanabe N; Goto A; Kamiya D; Watabe Y; Uchiyama T; Narita M; Takahashi M; Takahashi Y; Ishihara N; Miyazawa T; Yoshida T; Kawano M; Tamura M; Nashimoto M
    Leuk Res; 2014 Jul; 38(7):808-15. PubMed ID: 24768135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin in treatment of hematological cancers: Promises and challenges.
    Entezari M; Tayari A; Paskeh MDA; Kheirabad SK; Naeemi S; Taheriazam A; Dehghani H; Salimimoghadam S; Hashemi M; Mirzaei S; Samarghandian S
    J Tradit Complement Med; 2024 Mar; 14(2):121-134. PubMed ID: 38481552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies.
    Shapira S; Kazanov D; Mdah F; Yaakobi H; Herishanu Y; Perry C; Avivi I; Itchaki G; Shacham-Abulafia A; Raanani P; Hay-Levy M; Aiger G; Mashiah J; Lev-Ari S; Arber N
    J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steering Mast Cells or Their Mediators as a Prospective Novel Therapeutic Approach for the Treatment of Hematological Malignancies.
    Mehtani D; Puri N
    Front Oncol; 2021; 11():731323. PubMed ID: 34631562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting hematological malignancies with isoxazole derivatives.
    Majirská M; Pilátová MB; Kudličková Z; Vojtek M; Diniz C
    Drug Discov Today; 2024 Jun; 29(8):104059. PubMed ID: 38871112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Linking cellular metabolism to hematological malignancies, volume II.
    Liu Z; Yu J; Zhao ZJ; Shi H; Kashyap MK
    Front Oncol; 2024; 14():1387249. PubMed ID: 38655139
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Diagnosis and therapy pediatric hematological malignancies: recent progress.
    Zawitkowska J; Lejman M; Derwich K
    Front Pediatr; 2023; 11():1303561. PubMed ID: 37964814
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bacterial distribution and drug resistance of pathogens of blood stream infection in children with hematological malignancies after chemotherapy].
    Zheng YZ; Li J; Le SH; Zheng H; Hua XL; Chen ZS; Zheng L; Chen C; Hu JD
    Zhonghua Xue Ye Xue Za Zhi; 2019 Mar; 40(3):235-237. PubMed ID: 30929393
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells.
    Pelon M; Krzeminski P; Tracz-Gaszewska Z; Misiewicz-Krzeminska I
    Front Pharmacol; 2024; 15():1351565. PubMed ID: 38500772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes-mediated crosstalk between glioma and immune cells in the tumor microenvironment.
    Guo X; Sui R; Piao H
    CNS Neurosci Ther; 2023 Aug; 29(8):2074-2085. PubMed ID: 37170647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Purification, Modification, and Application of Extracellular Vesicles for Novel Clinical Treatments.
    Matsuzaka Y; Yashiro R
    Membranes (Basel); 2022 Dec; 12(12):. PubMed ID: 36557150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The status of industrialization and development of exosomes as a drug delivery system: A review.
    Yin Y; Han X; Li C; Sun T; Li K; Liu X; Liu M
    Front Pharmacol; 2022; 13():961127. PubMed ID: 36304147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.